“Silent” COVID-19 infections—cases in which individuals carried the virus without symptoms and avoided testing or isolation—likely exacerbated the pandemic’s early spread and distorted containment strategies, a novel QUT behavioral economics study has found.
For patients with Parkinson’s disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time versus placebo, according to a study presented at the annual meeting of the American Academy of Neurology, held from April 5 to 9 in San Diego.
For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA Ophthalmology.
Blue laser vaporization alleviates lower urinary tract symptoms while preserving sexual function in patients undergoing benign prostatic hyperplasia (BPH) surgery, according to a study published online March 4 in The Aging Male.
Federal cuts to funding could “decimate” medical research in the United States, delaying cures and costing countless lives, according to a leader in cancer research.
Severe and possibly deadly strep infections are on the rise in the U.S., according to a study published Monday in the Journal of the American Medical Association.
University of Florida scientists have helped identify a novel drug compound that selectively activates pain-altering receptors in the body, offering a potentially safer alternative to conventional pain medications.
People who suffer from the autoimmune disease myasthenia gravis experience muscle weakness that can affect any of the muscles we use to blink, smile or even move our body around.
Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 health care workers in Catalonia who were followed for three years. The study, led by ISGlobal in collaboration with the Fundación Privada Daniel Bravo Andreu (FPDBA) and published in Cell Reports, also shows that exposure to the virus prior to vaccination differentially imprints the immune systems without compromising the quality of the antibody response.
A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable “cytokine factory” that safely triggers potent immune responses against hard-to-treat cancers, including metastatic melanoma, pancreatic and colorectal tumors.